Stockscreener 앱 받기
7.84
2.12%
-0.17
시간 외 거래:
7.84
전일 마감가:
$8.01
열려 있는:
$8
하루 거래량:
12,052
Relative Volume:
0.25
시가총액:
$196.06M
수익:
$8.98M
순이익/손실:
$-31.39M
주가수익비율:
-5.7226
EPS:
-1.37
순현금흐름:
$-24.83M
1주 성능:
-3.92%
1개월 성능:
+1.16%
6개월 성능:
-5.43%
1년 성능:
-26.45%
1일 변동 폭
$7.77
$8.00
1주일 범위
$7.67
$8.2575
52주 변동 폭
$7.11
$11.69
프로파운드 메디컬 Stock (PROF) Company Profile
PROF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| PROF | 7.84 | 196.06M | 8.98M | -31.39M | -24.83M | -1.37 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
프로파운드 메디컬 Stock (PROF) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-04 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-15 | 개시 | Jefferies | Buy |
프로파운드 메디컬 주식(PROF)의 최신 뉴스
GAGNON SECURITIES LLC Acquires Shares in Profound Medical Corp - GuruFocus.com
Tom Tamberrino Joins Profound Medical as Chief Commercial Officer - MPO-mag
Opportunity Arises for Co. With Cell Pouch - Streetwise Reports
Profound Medical Corp. Announces Executive Changes - Marketscreener.com
Profound Medical to Present at Stifel Conference - TipRanks
Profound Medical to Participate in the Stifel 2024 Healthcare Conference - The Manila Times
Fact check: Are late-term abortions ever ‘medically necessary’? - Al Jazeera English
Profound Medical Corp. (NASDAQ:PROF) Q3 2024 Earnings Call Transcript - Insider Monkey
What is Raymond James' Forecast for TSE:PRN FY2028 Earnings? - MarketBeat
FY2028 Earnings Forecast for PROF Issued By Raymond James - MarketBeat
Profound Medical Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Profound Medical Corp (PROF) Q3 2024 Earnings Call Highlights: R - GuruFocus.com
Profound Medical Corp (PROF) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses - Yahoo Finance
Interventional Oncology Market Global Latest Trends and Insights 2024 to 2031 - Newstrail
A fantastic week for Profound Medical Corp.'s (TSE:PRN) 50% institutional owners, one-year returns continue to impress - Simply Wall St
Profound Medical (PROF) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Profound Medical Announces Third Quarter 2024 Financial Results - The Manila Times
10 Best Hearing Aids of November 2024: Expert Reviewed - National Council on Aging
Leede Financial Predicts TSE:PRN FY2024 Earnings - Defense World
Profound Medical Corp (TSX:PRN) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Leede Financial Comments on TSE:PRN FY2024 Earnings - MarketBeat
FY2024 Earnings Forecast for PROF Issued By Leede Financial - MarketBeat
Revolutionary AI Tools Take Center Stage in Medical Education Symposium - Streetwise Reports
Medical Co. Ready for a Transformative F2025 - Streetwise Reports
Canada Market top gains: Step Energy Services Ltd. gains 40.17% while Arizona Metals Corp. rises 16.67% at midday - Business Upturn
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025 - The Manila Times
When (PROF) Moves Investors should Listen - Stock Traders Daily
Profound Medical (TSX:PRN) Ending Cash Position : C$46.71 Mil (As of Jun. 2024) - GuruFocus.com
Profound Medical (PROF) to Release Quarterly Earnings on Thursday - MarketBeat
Profound Medical (PRN) Set to Announce Earnings on Thursday - MarketBeat
Learn to Evaluate (PROF) using the Charts - Stock Traders Daily
Profound Medical (TSE:PRN) Trading Down 0.2%Here's What Happened - MarketBeat
PainReform (NASDAQ:PRFX) Shares Up 11% – Here’s Why - Defense World
E.Merge Technology Acquisition (OTCMKTS:ETACU) Trading Down 1.5% – Here’s Why - Defense World
Profound Medical (NASDAQ:PROF) Trading Down 0.1%Here's What Happened - MarketBeat
Profound Medical to Release Third Quarter 2024 Financial Results on November 7Conference Call to Follow - The Manila Times
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference ... - The Hastings Tribune
Profound Medical Corp (PROF-Q) QuotePress Release - The Globe and Mail
Nevro announces new inducement grants - Medical Buyer
Tom Tamberrino named Profound Medical CCO - Medical Buyer
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer - Wallaceburg Courier Press
Economic Sector Performance Dashboards - Yahoo Finance
Debut Memoir by Visually Impaired Author, Jamie Roth, Makes Bestseller: 'I Lost One Vision, But Gained Another' - Yahoo Finance
iCAD to Participate in the LD Micro Main Event XVII - Newsfile
Trend Tracker for (PROF) - Stock Traders Daily
Owning 50% shares,institutional owners seem interested in Profound Medical Corp. (TSE:PRN), - Yahoo Finance
Profound Medical Corp (PROF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance UK
ROME Therapeutics, Enara Bio, Nucleome Therapeutics and NYU Langone Health to Host 3rd Annual Dark Genome Symposium - ForexTV.com
iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024 - Yahoo Finance
How to Take Advantage of moves in (PROF) - Stock Traders Daily
프로파운드 메디컬 (PROF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
0.43%
자본화:
|
볼륨(24시간):